Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01101 |
| Species: | Homo sapiens |
| Position : | chr1:214148800-214149632 |
| Year: | 2015 |
| Title: | GATA2 is required for lymphatic vessel valve development and maintenance |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 26214525 |
| MONDO: | |
| Tissue: | Forebrain |
| Tissue Ontology ID: | UBERON:0001890 |
| Cell Source: | Human neural progenitor cells (NPCs) |
| CVCL ID: | |
| Cell Type: | neural progenitor cell |
| Cell Ontology ID: | CL:0002672 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay |
| Target gene : | PROX1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|